Comorbidity and polypharmacy among people with HIV stratified by age, sex, and race

References

• U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. 2021. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV; [accessed 2022 Jun 22]. Available from: https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv/whats-new-guidelines
   Google Scholar
• Cahill S, Valadéz R. Growing older with HIV/AIDS: new public health challenges. Am J Public Health. 2013;103(3):e7–e15.
   PubMed Web of Science ®Google Scholar
• Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, et al. All-cause mortality in treated HIV-infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41:433–445.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–1533.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338(jan26 2):a3172–a3172.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–1126.
   PubMed Web of Science ®Google Scholar
• Brown TT, Hoy J, Borderi M, et al. Recommendations for evaluation and management of bone disease in HIV. Clin Infect Dis. 2015;60:1242–1251.
   PubMed Web of Science ®Google Scholar
• Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20(17):2165–2174.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Prakash M, Moecklinghoff C, et al. Morbidity in older HIV-infected patients: impact of long-term antiretroviral use. AIDS Rev. 2014;16(2):75–89.
   PubMed Web of Science ®Google Scholar
• Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J. 2014;35(21):1373–1381.
   PubMed Web of Science ®Google Scholar
• Islam FM, Wu J, Jansson J, et al. Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC Public Health. 2012;12(1):234.
   PubMedGoogle Scholar
• Triant VA, Brown TT, Lee H, et al. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab. 2008;93(9):3499–3504.
   PubMed Web of Science ®Google Scholar
• Group DADS, Sabin CA, Worm SW, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet. 2008;371:1417–1426.
   PubMed Web of Science ®Google Scholar
• Hsue PY, Scherzer R, Hunt PW, et al. Carotid intima-media thickness progression in HIV-infected adults occurs preferentially at the carotid bifurcation and is predicted by inflammation. J Am Heart Assoc. 2012;1(2):1.
   PubMed Web of Science ®Google Scholar
• Childs K, Welz T, Samarawickrama A, et al. Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. AIDS. 2012;26(3):253–262.
   PubMed Web of Science ®Google Scholar
• Mills A, Crofoot G Jr, McDonald C, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate in the first protease inhibitor-based single-tablet regimen for initial HIV-1 therapy: a randomized phase 2 study. J Acquir Immune Defic Syndr. 2015;69(4):439–445.
   PubMed Web of Science ®Google Scholar
• Mocroft A, Kirk O, Reiss P, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010;24(11):1667–1678.
   PubMed Web of Science ®Google Scholar
• Hill A, Hughes SL, Gotham D, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? J Virus Erad. 2018;4:72–79.
   PubMed Web of Science ®Google Scholar
• Paudel M, Prajapati G, Buysman EK, et al. Comorbidity and comedication burden among people living with HIV in the United States. Curr Med Res Opin. 2022;38:1443–1450.
   PubMed Web of Science ®Google Scholar
• US Census. Census Regions and Divisions of the United States. Available from: https://www2.census.gov/programs-surveys/sahie/reference-maps/2017/us-regdiv.pdf. Accessed on 20 July 2022.
   Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Clinical Classification Software (CCS) for ICD-9-CM. Available from: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp (discharges prior to 10/1/2015). Accessed on 21 June 2022.
   Google Scholar
• Centers for Medicare and Medicaid Services. Chronic Conditions Data Warehouse (CCW). Available from: https://www2.ccwdata.org/web/guest/condition-categories. Accessed on 21 June 2022.
   Google Scholar
• Priest JL, Burton T, Blauer-Peterson C, et al. Clinical characteristics and treatment patterns among US patients with HIV. Am J Manag Care. 2019;25(12):580–586.
   PubMed Web of Science ®Google Scholar
• Friedman EE, Duffus WA. Chronic health conditions in Medicare beneficiaries 65 years old, and older with HIV infection. AIDS. 2016;30(16):2529–2536.
   PubMed Web of Science ®Google Scholar
• Gallant J, Hsue PY, Shreay S, et al. Comorbidities among US patients with prevalent HIV infection-a trend analysis. J Infect Dis. 2017;216(12):1525–1533.
   PubMed Web of Science ®Google Scholar
• Richterman A, Sax PE. Antiretroviral therapy in older people with HIV. Curr Opin HIV AIDS. 2020;15(2):118–125.
   PubMed Web of Science ®Google Scholar
• Shah S, Hill A. Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy: republication. Curr Opin HIV AIDS. 2021;16(2):106–114.
   PubMed Web of Science ®Google Scholar
• Venter WDF, Sokhela S, Simmons B, et al. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Lancet HIV. 2020;7(10):e666–e676.
   PubMed Web of Science ®Google Scholar
• Rao SG, Galaviz KI, Gay HC, et al. Factors associated with excess myocardial infarction risk in HIV-Infected adults: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2019;81(2):224–230.
   PubMed Web of Science ®Google Scholar
• Mills AM, Antinori A, Clotet B, et al. Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment-naive, HIV-1-infected patients at 48 weeks. HIV Med. 2013;14:391–400.
   PubMed Web of Science ®Google Scholar
• Nelson M, Stellbrink HJ, Podzamczer D, et al. A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population. AIDS. 2011;25(3):335–340.
   PubMed Web of Science ®Google Scholar
• Emmons RP, Hastain NV, Miano TA, et al. Patients living with HIV are less likely to receive appropriate statin therapy for cardiovascular disease risk reduction. J Pharm Pract. 2021;35(4):568–572.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Malagoli A, Calcagno A, et al. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years. BMC Geriatr. 2018;18(1):99.
   PubMed Web of Science ®Google Scholar
• Kong AM, Pozen A, Anastos K, et al. Non-HIV comorbid conditions and polypharmacy among people living with HIV age 65 or older compared with HIV-Negative individuals age 65 or older in the United States: a retrospective claims-based analysis. AIDS Patient Care STDS. 2019;33:93–103.
   PubMed Web of Science ®Google Scholar